Scott Floyd
Papers
2
Total Citations
38
H-Index
2
About
Scott Floyd is a clinician-scientist whose research bridges radiation oncology and DNA damage repair, with a particular focus on improving therapeutic outcomes for brain tumors. His key contributions lie in two intersecting areas: optimizing radiation delivery for skull base tumors and developing high-throughput tools to study cellular responses to DNA damage. In his seminal 2011 study on hypofractionated stereotactic radiotherapy (HSRT) for benign skull base tumors, Floyd demonstrated that this approach offers effective tumor control while minimizing the morbidity associated with surgical resection—a finding that has garnered 35 citations and influenced clinical practice for patients with challenging cranial base lesions. More recently, Floyd has advanced the field of DNA repair biology through his work on the HTS-Compatible CometChip, a high-throughput screening platform that enables genetic interrogation of apoptosis and double-strand break repair pathways. This innovative tool, published in 2020, holds promise for identifying novel therapeutic targets and radiosensitizers. By combining clinical outcomes research with cutting-edge genetic screening, Floyd exemplifies the translational researcher, directly linking mechanistic insights to improved patient care in radiation oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2